Clinical Effectiveness of Hybrid Capture-Based Massive Parallel Sequencing in Therapeutic Strategy Planning in Lung Cancer

被引：0

作者：

Rozenblum, Anna Belilovski ^{[1
]}

Ilouze, Maya ^{[1
]}

Dudnik, Elizabeth ^{[1
]}

Dvir, Addie ^{[2
]}

Soussan-Gutman, Lior ^{[2
]}

Geva, Smadar ^{[1
]}

Peled, Nir ^{[1
]}

机构：

[1] Rabin Med Ctr, Davidoff Canc Ctr, Thorac Canc Serv, Petah Tiqwa, Israel

[2] Teva Pharmaceut Ind Ltd, Shoam, Israel

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

massive parallel sequencing; Driver Mutations; Targeted therapy; Immunotherapy;

D O I：

10.1016/j.jtho.2016.11.1314

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.03b033

引用

页码：S954 / S955

页数：2

共 50 条

[1] Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer
Rozenblum, Anna Belilovski
Ilouze, Maya
Dudnik, Elizabeth
Dvir, Addie
Soussan-Gutman, Lior
Geva, Smadar
Peled, Nir
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 258 - 268
[2] A newly developed capture-based sequencing panel for genomic assay of lung cancer
Im, Sun-Wha
Chae, Jeesoo
Jang, Se Song
Choi, Jaeyong
Yun, Jihui
Cha, Soojin
Kwon, Nak-Jung
Jeon, Yoon Kyung
Hwang, Yoohwa
Kim, Miso
Kim, Tae Min
Kim, Dong-Wan
Kim, Jong-Il
Kim, Young Tae
GENES & GENOMICS, 2020, 42 (07) : 751 - 759
[3] A newly developed capture-based sequencing panel for genomic assay of lung cancer
Sun-Wha Im
Jeesoo Chae
Se Song Jang
Jaeyong Choi
Jihui Yun
Soojin Cha
Nak-Jung Kwon
Yoon Kyung Jeon
Yoohwa Hwang
Miso Kim
Tae Min Kim
Dong-Wan Kim
Jong-Il Kim
Young Tae Kim
Genes & Genomics, 2020, 42 : 751 - 759
[4] The minimal amount of starting DNA for Agilent’s hybrid capture-based targeted massively parallel sequencing
Jongsuk Chung
Dae-Soon Son
Hyo-Jeong Jeon
Kyoung-Mee Kim
Gahee Park
Gyu Ha Ryu
Woong-Yang Park
Donghyun Park
Scientific Reports, 6
[5] The minimal amount of starting DNA for Agilent's hybrid capture-based targeted massively parallel sequencing
Chung, Jongsuk
Son, Dae-Soon
Jeon, Hyo-Jeong
Kim, Kyoung-Mee
Park, Gahee
Ryu, Gyu Ha
Park, Woong-Yang
Park, Donghyun
SCIENTIFIC REPORTS, 2016, 6
[6] Comparison of custom designed gene panels for hybrid capture-based parallel sequencing in molecular pathology routine diagnostics
Heydt, C.
Baar, T.
Wagener, S.
Ihle, M. A.
Carl, C.
Fassunke, J.
Buettner, R.
Merkelbach-Bruse, S.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S50 - S51
[7] Comprehensive Assessment of Targetable Driver Alterations in Lung Adenocarcinomas Using a Clinical, Hybrid Capture-Based, Next-Generation Sequencing Assay
Arcila, Maria
Zehir, Ahmet
Cheng, Donavan
Yu, Helena
Kris, Marc
Drilon, Alexander
Riely, Gregory
Boger, Michael
Ladanyi, Marc
MODERN PATHOLOGY, 2015, 28 : 511A - 511A
[8] Comprehensive Assessment of Targetable Driver Alterations in Lung Adenocarcinomas Using a Clinical, Hybrid Capture-Based, Next-Generation Sequencing Assay
Arcila, Maria
Zehir, Ahmet
Cheng, Donavan
Yu, Helena
Kris, Marc
Drilon, Alexander
Riely, Gregoty
Berger, Michael
Ladanyi, Marc
LABORATORY INVESTIGATION, 2015, 95 : 511A - 511A
[9] Broad, hybrid capture-based next generation sequencing guided personalized therapy in metastatic colorectal cancer
Hou, Helei
Zhang, Chuantao
Liu, Dong
Zhou, Na
Xu, Xiaomei
Deng, Lihua
Zhang, Jinping
Lv, Hongying
Zhu, Jingjuan
Zhang, Xiaoping
Yang, Xiaonan
Zhu, Shida
Li, Zhuokun
Zhu, Hongmei
Zhang, Xiaochun
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[10] Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing
Szymansky, Annabell
Kruetzfeldt, Louisa-Marie
Heukamp, Lukas C.
Hertwig, Falk
Theissen, Jessica
Deubzer, Hedwig E.
Willing, Eva-Maria
Menon, Roopika
Fuchs, Steffen
Thole, Theresa
Schulte, Stefanie
Schmelz, Karin
Kuenkele, Annette
Lang, Peter
Fuchs, Joerg
Eggert, Angelika
Eckert, Cornelia
Fischer, Matthias
Henssen, Anton G.
Rodriguez-Fos, Elias
Schulte, Johannes H.
JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):

← 1 2 3 4 5 →